Hongyan Zhong
Pharmacyclics (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Pulmonary Hypertension Research and Treatments, Mast cells and histamine, Microbial metabolism and enzyme function, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment(2016)264 cited
- → Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction(2000)206 cited
- → Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A 2B Angiogenic Phenotype(2004)163 cited
- → A2B Adenosine Receptors Increase Cytokine Release by Bronchial Smooth Muscle Cells(2003)148 cited
- → Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts(2004)146 cited
- → Activation of Murine Lung Mast Cells by the Adenosine A3 Receptor(2003)142 cited
- → A3 Adenosine Receptor Signaling Contributes to Airway Inflammation and Mucus Production in Adenosine Deaminase-Deficient Mice(2004)122 cited
- → A2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-α Increase(2006)104 cited
- → The Use of Enzyme Therapy to Regulate the Metabolic and Phenotypic Consequences of Adenosine Deaminase Deficiency in Mice(2000)92 cited
- → The A 2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease(2012)90 cited